Staffed by oncology professionals and insurance experts, ITA Partners provides credible, objective, 3rd-party cancer risk-management services for insurers. We’re easy to work with because we understand your business and have tailored our services and processes to it.
ITA facilitates quality care that meets evidence-based guidelines and insurance policy provisions. Bottom line: Our intervention results in better medical outcomes and saves thousands of dollars for your members diagnosed with cancer.
We speak peer-to-peer with attending physicians and support your members so they make well-informed decisions and take excellent care of themselves. We understand whether care complies with evidence-based, national guidelines, whether it is priced appropriately, and whether it is consistent with health-plan policy language. If not, we have the track record, objectivity, and credibility to intervene.
OncoIQSM, our proprietary electronic system, provides real-time decision support to help payers manage financial risk. It validates treatment alignment with evidence-based guidelines and for consistency with policy language. OncoIQSM keeps an electronic record for each patient, and its reporting shows you what’s happening with your members: where they are in treatment, how we’ve helped prevent complications, and how we’ve arranged cost-effective treatment delivery options.
|
 |
ITA delivers a 5:1 average yearly return on investment to clients. |
|
Our services integrate easily into your existing plan structure. |
|
We work with more than 120 third-party administrators. |
|
Standards-driven and evidence-based, we’re up-to-date on emerging
cancer research. |
|
We’re independent — not a network, and not part of an insurance company. |
|
We validate treatment plans so you and your members pay only for
appropriate treatment. |
|
We increase patient compliance with at-home care plans and minimize side effects, complications and unnecessary or erroneous interventions. |
|
Regular reports summarize our unique, clinical insight and risk-reduction interventions that lead to verifiable savings. |
| |
How ITA Achieves Better Outcomes
|
|
|
When Bill, 53,
was referred to
ITA Partners
through his
employer’s stop-
loss carrier, he was being treated for acute myeloid leukemia at a top academic medical center.
His hematologist had helped set national care guidelines. Yet, ITA still brought vast value for Bill, his physicians, and his insurers. |
|
